Information
GALWAY, Ireland , Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthc...
Original sourceAI Summary
Medtronic will report Q3 fiscal year 2025 results on February 18, 2025. A webcast will discuss the financial results at 7:00 a.m. CST. Q4 fiscal year 2025 results are planned for May 21, 2025. Fiscal year 2026 results reporting schedule is outlined for all quarters. Medtronic's diverse technologies address numerous health conditions globally.
Sentiment Rationale
While earnings reports are significant, no immediate catalysts influence MDT's current price trajectory.
Trading Thesis
Quarterly results may affect investor sentiment long-term but not in the short-term.
Market-Moving
- Medtronic will report Q3 fiscal year 2025 results on February 18, 2025.
- A webcast will discuss the financial results at 7:00 a.m. CST.
- Q4 fiscal year 2025 results are planned for May 21, 2025.
Key Facts
- Medtronic will report Q3 fiscal year 2025 results on February 18, 2025.
- A webcast will discuss the financial results at 7:00 a.m. CST.
- Q4 fiscal year 2025 results are planned for May 21, 2025.
- Fiscal year 2026 results reporting schedule is outlined for all quarters.
- Medtronic's diverse technologies address numerous health conditions globally.
Companies Mentioned
- MDT (MDT)
- ABT (ABT)
- SYK (SYK)
Earnings
Earnings reports are typically crucial, but this announcement lacks immediate impactful news.